Device manufacturer, as written on reports
Caldera Medical: medical device reports filed with FDA
1,077 reports name it as the manufacturer of the device involved, 2009–2026.
- 1,077
- reports naming it as manufacturer
- 0% of all MAUDE reports
- 238
- reports, 12 months to August 2026
- 29 in the 12 months before
- 7.1%
- classified as malfunction
- 62.3% across all reports
- 0%
- classified as death, as reported
- 0.9% across all reports
1,077 medical device reports received by FDA give Caldera Medical as the manufacturer of the device involved, 0% of the MAUDE database, from May 2009 to July 2026. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.
238 reports arrived in the 12 months to August 2026, up 721% from 29 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (91%), malfunction (7.1%) and other (1.8%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands named most often
| Brand | Device type | Reports | Latest 12 months | Classified as death |
|---|---|---|---|---|
| Desara | Mesh, surgical, synthetic, urogynecologic, for stress urinary incontinence, retropubic or transobturator | 292 | 0 | 0% |
| Tvt Exact Retropubic System | Mesh, surgical, synthetic, urogynecologic, for stress urinary incontinence, retropubic or transobturator | 55 | 49 | 0% |
| T-Sling | Mesh, surgical, synthetic, urogynecologic, for stress urinary incontinence, female, mini-sling | 28 | 0 | 0% |
| Tension Free Vaginal Tape - Exact Unknown Product | Mesh, surgical, synthetic, urogynecologic, for stress urinary incontinence, retropubic or transobturator | 28 | 28 | 0% |
| Tension Free Vaginal Tape Unknown Product | Mesh, surgical, synthetic, urogynecologic, for stress urinary incontinence, retropubic or transobturator | 24 | 24 | 0% |
| Gynecare Tvt Obturator | Mesh, surgical, synthetic, urogynecologic, for stress urinary incontinence, retropubic or transobturator | 17 | 15 | 0% |
| Gynecare Tvt Obturator W Lasr | Mesh, surgical, synthetic, urogynecologic, for stress urinary incontinence, retropubic or transobturator | 14 | 14 | 0% |
| Tension Free Vaginal Tape - Obturator Unknown Prod | Mesh, surgical, synthetic, urogynecologic, for stress urinary incontinence, retropubic or transobturator | 5 | 5 | 0% |
| Gynecare Tvt-Abbrevo Mini Lcm | Mesh, surgical, synthetic, urogynecologic, for stress urinary incontinence, retropubic or transobturator | 4 | 4 | 0% |
| Gynecare TVT | Mesh, surgical, synthetic, urogynecologic, for stress urinary incontinence, retropubic or transobturator | 2 | 3 | 0% |
Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Device types
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type
Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.
Questions about Caldera Medical reports
How many FDA device reports name Caldera Medical as manufacturer?
1,077 reports through August 2026, 238 of them in the latest 12 months.
Which of its brands appear most often?
Desara (292), Tvt Exact Retropubic System (55), T-Sling (28), Tension Free Vaginal Tape - Exact Unknown Product (28) and Tension Free Vaginal Tape Unknown Product (24).
Which device types does it report on?
mesh, surgical, polymeric (52%), mesh, surgical, synthetic, urogynecologic, for stress urinary incontinence, retropubic or transobturator (40.1%), mesh, surgical, synthetic, urogynecologic, for stress urinary incontinence, female, mini-sling (4.1%) and mesh, surgical, synthetic, urogynecologic, for apical vaginal and uterine prolapse, transabdominally placed (1.8%).
Does a high count say something about the manufacturer?
Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.